Carlos Nueno Sells 6,196 Shares of Teladoc Health (NYSE:TDOC) Stock

Teladoc Health, Inc. (NYSE:TDOC) insider Carlos Nueno sold 6,196 shares of the business’s stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $7.63, for a total transaction of $47,275.48. Following the sale, the insider directly owned 57,671 shares of the company’s stock, valued at approximately $440,029.73. The trade was a 9.70% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Teladoc Health Trading Up 2.8%

Shares of TDOC stock opened at $7.29 on Friday. Teladoc Health, Inc. has a 1 year low of $4.40 and a 1 year high of $9.77. The firm has a fifty day moving average price of $6.17 and a 200-day moving average price of $6.22. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.80 and a quick ratio of 2.72. The company has a market cap of $1.32 billion, a price-to-earnings ratio of -7.51 and a beta of 2.14.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings data on Wednesday, April 29th. The health services provider reported ($0.36) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.35) by ($0.01). Teladoc Health had a negative net margin of 6.81% and a negative return on equity of 11.45%. The business had revenue of $613.85 million for the quarter, compared to the consensus estimate of $611.04 million. During the same period in the previous year, the firm earned ($0.53) EPS. The company’s revenue was down 2.5% on a year-over-year basis. Teladoc Health has set its FY 2026 guidance at -1.050–0.750 EPS and its Q2 2026 guidance at -0.300–0.200 EPS. As a group, equities analysts predict that Teladoc Health, Inc. will post -0.91 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on TDOC. Wells Fargo & Company dropped their target price on shares of Teladoc Health from $8.00 to $6.00 and set an “equal weight” rating for the company in a report on Thursday, February 26th. Weiss Ratings raised shares of Teladoc Health from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, May 22nd. Canaccord Genuity Group dropped their target price on shares of Teladoc Health from $12.00 to $10.00 and set a “buy” rating for the company in a report on Thursday, February 26th. JPMorgan Chase & Co. dropped their target price on shares of Teladoc Health from $9.00 to $7.00 and set a “neutral” rating for the company in a report on Friday, March 13th. Finally, Stifel Nicolaus dropped their target price on shares of Teladoc Health from $8.00 to $6.00 and set a “hold” rating for the company in a report on Thursday, February 26th. Five analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $7.43.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Federated Hermes Inc. raised its position in shares of Teladoc Health by 0.5% during the 3rd quarter. Federated Hermes Inc. now owns 307,700 shares of the health services provider’s stock valued at $2,379,000 after buying an additional 1,450 shares in the last quarter. Creative Planning raised its position in shares of Teladoc Health by 7.7% during the 3rd quarter. Creative Planning now owns 20,567 shares of the health services provider’s stock valued at $159,000 after buying an additional 1,462 shares in the last quarter. Krane Funds Advisors LLC raised its position in shares of Teladoc Health by 13.4% during the 3rd quarter. Krane Funds Advisors LLC now owns 12,431 shares of the health services provider’s stock valued at $106,000 after buying an additional 1,469 shares in the last quarter. State of Wyoming raised its position in shares of Teladoc Health by 2.1% during the 3rd quarter. State of Wyoming now owns 79,075 shares of the health services provider’s stock valued at $611,000 after buying an additional 1,628 shares in the last quarter. Finally, Syon Capital LLC raised its position in shares of Teladoc Health by 19.1% during the 4th quarter. Syon Capital LLC now owns 14,140 shares of the health services provider’s stock valued at $99,000 after buying an additional 2,264 shares in the last quarter. Institutional investors own 76.82% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.